Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Brain Function Effects of Guanfacine and Lisdexamfetamine in ADHD
NCT03333668Completed
- Sponsor
- King's College London
- Start
- Oct 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Lisdexamfetamine - Placebo, Guanfacine - Placebo and Lisdexamfetamine - Guanfacine (3 arms). Primary endpoint: Change in brain activation under the three drug conditions at 2 weeks. Started Oct 2018; status: completed.
02
Drugs
guanfacinelisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03333668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333668.